Literature DB >> 9927186

Inhibitory effect of Bcl-2 on p53-mediated transactivation following genotoxic stress.

Q Zhan1, U Kontny, M Iglesias, I Alamo, K Yu, M C Hollander, C D Woodworth, A J Fornace.   

Abstract

In the cellular response to genotoxic stress, cell cycle checkpoint and apoptosis are considered to be two of the major biological events in maintaining genomic stability. The tumor suppressor p53 has been shown to play critical roles in these stress-induced cellular responses at least in part through the activation of its down-stream genes, such as p21CIP1/WAF1, GADD45 and BAX. In addition, p53 has been found to down-regulate the expression of BCL-2, which is able to block apoptosis induced by both p53-dependent and independent signaling events. In this report, we have found that increased expression of Bcl-2 protein in the human Burkitt's lymphoma WMN cell line suppressed apoptosis induced by different DNA-damaging agents. The induction of p53-regulated genes including GADD45, p21CIP1/WAF1 and BAX by genotoxic stress was substantially reduced in cells expressing high levels of Bcl-2 protein. Furthermore, Bcl-2 protein was shown to specifically suppress the p53-mediated transactivation of p21CIP1/WAF1 and PG13-CAT, which is a typical p53-binding-site reporter construct. Similarly, the inhibitory effect of Bcl-2 protein was seen in a GADD45 promoter reporter construct after treatment with methylmethane sulfonate or UV-radiation. These results indicate that in addition to its apoptosis-suppressing activity, Bcl-2 protein is able to inhibit transactivation of p53-regulated genes, which function in multiple important cellular responses to genotoxic stress, including the control of cell cycle checkpoints, cell growth suppression and DNA repair.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927186     DOI: 10.1038/sj.onc.1202310

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  The complexity of radiation stress responses: analysis by informatics and functional genomics approaches.

Authors:  A J Fornace; S A Amundson; M Bittner; T G Myers; P Meltzer; J N Weinsten; J Trent
Journal:  Gene Expr       Date:  1999

2.  Analysis of stress responsive genes induced by single-walled carbon nanotubes in BJ Foreskin cells.

Authors:  Shubhashish Sarkar; Chidananda Sharma; Rajeshwari Yog; Adaikkappan Periakaruppan; Olufisayo Jejelowo; Renard Thomas; Enrique V Barrera; Allison C Rice-Ficht; Bobby L Wilson; Govindarajan T Ramesh
Journal:  J Nanosci Nanotechnol       Date:  2007-02

3.  Antisense Bcl-2 sensitizes prostate cancer cells to radiation.

Authors:  Zhaomei Mu; Paul Hachem; Alan Pollack
Journal:  Prostate       Date:  2005-12-01       Impact factor: 4.104

4.  Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.

Authors:  Amandine Savry; Manon Carre; Raphael Berges; Amandine Rovini; Isabelle Pobel; Christine Chacon; Diane Braguer; Véronique Bourgarel-Rey
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

5.  Knockdown of Gli1 by small-interfering RNA enhances the effects of BCNU on the proliferation and apoptosis of glioma U251 cells.

Authors:  Wenjia Guo; Hailong Tian; Xiaogang Dong; Jinping Bai; Xinling Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Promoting optic nerve regeneration in adult mice with pharmaceutical approach.

Authors:  Kin-Sang Cho; Dong Feng Chen
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

7.  Genomic and proteomic analysis of the impact of mitotic quiescence on the engraftment of human CD34+ cells.

Authors:  Brahmananda Reddy Chitteti; Yunlong Liu; Edward F Srour
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

8.  Administration of ON 01210.Na after exposure to ionizing radiation protects bone marrow cells by attenuating DNA damage response.

Authors:  Shubhankar Suman; Manoj Maniar; Albert J Fornace; Kamal Datta
Journal:  Radiat Oncol       Date:  2012-01-20       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.